Annual report pursuant to section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

v2.4.0.6
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (USD $)
12 Months Ended 178 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2012
Income Statement [Abstract]      
Net sales       $ 69,000
Cost of goods sold       24,120
Gross profit       44,880
Operating expenses 7,457,170 6,886,681 51,601,805
Research and development expenses 693,184 1,130,283 8,138,181
Non-cash patent settlement cost       1,610,066
Loss before other income (expense) (8,150,354) (8,016,964) (61,305,172)
Other income (loss) 24,723 48,000 216,695
Interest income       16,342
Interest and financing expense (3,627,732) (5,084,253) (20,304,349)
Change in fair value of derivative liabilities (4,023,094) 2,021,536 (1,894,893)
Gain on extinguishment of derivative liabilities 2,445,095    2,445,095
Costs of private placement       (1,640,715)
Costs to induce conversion of notes       (469,043)
Loss on disposition of equipment       (14,426)
Settlement of Debt Due Morale/ Matthews       (927,903)
Settlement of litigation and debt 239,775 175,934 1,504,797
Loss before provision for income taxes (13,091,587) (10,855,747) (82,373,572)
Provision for income taxes 800 800 8,282
Net loss $ (13,092,387) $ (10,856,547) $ (82,381,854)
Net loss per common share, basic and diluted $ (0.10) $ (0.10)  
Weighted average common shares outstanding,basic and diluted 128,667,391 104,103,109